Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Class II · Moderate risk

0.9% Sodium Chloride Injection

Lack of Assurance of Sterility:Solution leaking through the port cover of the primary container, which was identified during a retain sample visual inspection.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7983-09 D-1096-2014
Class II · Moderate risk

ROHTO Redness Relief

Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.

Terminated Sterility / contamination The Mentholatum Co. D-1041-2014
Class II · Moderate risk

ROHTO Cooling Eye Drops

Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.

Terminated Sterility / contamination The Mentholatum Co. D-1040-2014
Class II · Moderate risk

ROHTO Dry Eye

Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.

Terminated Sterility / contamination The Mentholatum Co. D-1039-2014
Class II · Moderate risk

ROHTO Redness Relief

Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.

Terminated Sterility / contamination The Mentholatum Co. D-1038-2014
Class II · Moderate risk

ROHTO Redness Relief

Lack of Assurance of Sterility: The Mentholatum Company has recalled Rohto Arctic, Rohto Ice, Rohto Hydra, Rohto Relief and Rohto Cool eye drops, due to concerns related to the quality assurance of sterility controls.

Terminated Sterility / contamination The Mentholatum Co. D-1037-2014
Class II · Moderate risk

Vitamin B-12 injections

Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm.

Terminated Sterility / contamination Zions RX Formulations Services LLC dba RX Formuations Serv. D-1219-2014
Class II · Moderate risk

Bupivacaine 3%

Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm.

Terminated Sterility / contamination Zions RX Formulations Services LLC dba RX Formuations Serv. D-1218-2014
Class II · Moderate risk

Sodium Bicarbonate 8.4%

Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm.

Terminated Sterility / contamination Zions RX Formulations Services LLC dba RX Formuations Serv. D-1217-2014
Class II · Moderate risk

Potassium Phosphates 4.4mEq/3mM/mL Vials

Lack of Assurance of Sterility: The firm expanded the recall to other injectable products due to lack of assurance of sterility from poor aseptic practices observed at the firm.

Terminated Sterility / contamination Zions RX Formulations Services LLC dba RX Formuations Serv. D-1215-2014
Class I · High risk

Calcium Gluconate 10% for Injection

Non-Sterility: RX Formulation initiated this recall due to a report of microbial contamination found in Calcium Gluconate saturated solution that was observed upon drawing the vial contents into a syringe.

Terminated Sterility / contamination Zions RX Formulations Services LLC dba RX Formuations Serv. D-1213-2014
Class I · High risk

Glycopyrrolate

Non-Sterility: One lot of Glycopyrrolate solution for injection was found to be contaminated with Bacillus thuringiensis.

Terminated Sterility / contamination Brookfield Prescription Center Inc D-1252-2014
Class II · Moderate risk

10%, Travasol

Lack of Assurance of Sterility; Drug product leaking from container therefore sterility cannot be assured

Terminated Sterility / contamination Baxter Healthcare Corp. D-368-2014
Class II · Moderate risk

Sumatriptan Succinate Injection

Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.

Terminated Sterility / contamination GlaxoSmithKline, LLC. NDC 0781-3173-07 D-388-2014
Class II · Moderate risk

Imitrex STATdose System

Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.

Terminated Sterility / contamination GlaxoSmithKline, LLC. NDC 0173-0479-00 D-387-2014
Class II · Moderate risk

PEGASPARGASE ONCASPAR Injection

Lack of Assurance of Sterility: Sigma-Tau PharmaSource, Inc. is conducting a voluntary recall of five lots of Oncaspar Injection, because of a crack under the crimp seal which caused a leak.

Terminated Sterility / contamination Sigma-Tau Pharmaceuticals, Inc. NDC 54482-301-01 D-736-2014